SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:lup.lub.lu.se:34a61787-87be-4c81-8742-e546b4df2559"
 

Search: onr:"swepub:oai:lup.lub.lu.se:34a61787-87be-4c81-8742-e546b4df2559" > IL-33 blockade affe...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

IL-33 blockade affects mediators of persistence and exacerbation in a model of chronic airway inflammation

Allinne, Jeanne (author)
Regeneron Pharmaceuticals, Inc.
Scott, George (author)
Regeneron Pharmaceuticals, Inc.
Lim, Wei Keat (author)
Regeneron Pharmaceuticals, Inc.
show more...
Birchard, Dylan (author)
Regeneron Pharmaceuticals, Inc.
Erjefält, Jonas S. (author)
Lund University,Lunds universitet,Luftvägsinflammation,Forskargrupper vid Lunds universitet,Airway Inflammation and Immunology,Lund University Research Groups,Medetect AB
Sandén, Caroline (author)
Medetect AB
Ben, Li Hong (author)
Regeneron Pharmaceuticals, Inc.
Agrawal, Amit (author)
Regeneron Pharmaceuticals, Inc.
Kaur, Navneet (author)
Regeneron Pharmaceuticals, Inc.
Kim, Jee Hae (author)
Regeneron Pharmaceuticals, Inc.
Kamat, Vishal (author)
Regeneron Pharmaceuticals, Inc.
Fury, Wen (author)
Regeneron Pharmaceuticals, Inc.
Huang, Tammy (author)
Regeneron Pharmaceuticals, Inc.
Stahl, Neil (author)
Regeneron Pharmaceuticals, Inc.
Yancopoulos, George D. (author)
Regeneron Pharmaceuticals, Inc.
Murphy, Andrew J. (author)
Regeneron Pharmaceuticals, Inc.
Sleeman, Matthew A. (author)
Regeneron Pharmaceuticals, Inc.
Orengo, Jamie M. (author)
Regeneron Pharmaceuticals, Inc.
show less...
Regeneron Pharmaceuticals, Inc Luftvägsinflammation (creator_code:org_t)
Elsevier BV, 2019
2019
English 24 s.
In: Journal of Allergy and Clinical Immunology. - : Elsevier BV. - 0091-6749. ; 144:6, s. 1624-1637
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Background: Severe inflammatory airway diseases are associated with inflammation that does not resolve, leading to structural changes and an overall environment primed for exacerbations. Objective: We sought to identify and inhibit pathways that perpetuate this heightened inflammatory state because this could lead to therapies that allow for a more quiescent lung that is less predisposed to symptoms and exacerbations. Methods: Using prolonged exposure to house dust mite in mice, we developed a mouse model of persistent and exacerbating airway disease characterized by a mixed inflammatory phenotype. Results: We show that lung IL-33 drives inflammation and remodeling beyond the type 2 response classically associated with IL-33 signaling. IL-33 blockade with an IL-33 neutralizing antibody normalized established inflammation and improved remodeling of both the lung epithelium and lung parenchyma. Specifically, IL-33 blockade normalized persisting and exacerbating inflammatory end points, including eosinophilic, neutrophilic, and ST2+CD4+ T-cell infiltration. Importantly, we identified a key role for IL-33 in driving lung remodeling because anti–IL-33 also re-established the presence of ciliated cells over mucus-producing cells and decreased myofibroblast numbers, even in the context of continuous allergen exposure, resulting in improved lung function. Conclusion: Overall, this study shows that increased IL-33 levels drive a self-perpetuating amplification loop that maintains the lung in a state of lasting inflammation and remodeled tissue primed for exacerbations. Thus IL-33 blockade might ameliorate symptoms and prevent exacerbations by quelling persistent inflammation and airway remodeling.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Lungmedicin och allergi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Respiratory Medicine and Allergy (hsv//eng)

Keyword

airway inflammation
airway remodeling
anti–IL-33
asthma
exacerbation
house dust mite
IL-33

Publication and Content Type

art (subject category)
ref (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view